Neuroinflammation in healthy aging: A PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [18F]-FEPPA

One of the cellular markers of neuroinflammation is increased microglia activation, characterized by overexpression of mitochondrial 18kDa Translocator Protein (TSPO). TSPO expression can be quantified in-vivo using the positron emission tomography (PET) radioligand [(18)F]-FEPPA. This study examined microglial activation as measured with [(18)F]-FEPPA PET across the adult lifespan in a group of healthy volunteers. We performed genotyping for the rs6971 TS.PO gene polymorphism to control for the known variability in binding affinity. Thirty-three healthy volunteers (age range: 19-82years; 22 high affinity binders (HAB), 11 mixed affinity binders (MAB)) underwent [(18)F]-FEPPA PET scans, acquired on the High Resolution Research Tomograph (HRRT) and analyzed using a 2-tissue compartment model. Regression analyses were performed to examine the effect of age adjusting for genetic status on [(18)F]-FEPPA total distribution volumes (VT) in the hippocampus, temporal, and prefrontal cortex. We found no significant effect of age on [(18)F]-FEPPA VT (F (1,30)=0.918; p=0.346), and a significant effect of genetic polymorphism (F (1,30)=8.767; p=0.006). This is the first in-vivo study to evaluate age-related changes in TSPO binding, using the new generation TSPO radioligands. Increased neuroinflammation, as measured with [(18)F]-FEPPA PET was not associated with normal aging, suggesting that healthy elderly individuals may serve as useful benchmark against patients with neurodegenerative disorders where neuroinflammation may be present.

[1]  J. Sloane,et al.  Increased microglial activation and protein nitration in white matter of the aging monkey☆ , 1999, Neurobiology of Aging.

[2]  A. Peters,et al.  Neuroglial cells in the cerebral cortex of rats from young adulthood to old age: An electron microscope study , 1974, Journal of neurocytology.

[3]  F. Yasuno,et al.  Increased Binding of Peripheral Benzodiazepine Receptor in Alzheimer's Disease Measured by Positron Emission Tomography with [11C]DAA1106 , 2008, Biological Psychiatry.

[4]  Shitij Kapur,et al.  An automated method for the extraction of regional data from PET images , 2006, Psychiatry Research: Neuroimaging.

[5]  C. Braestrup,et al.  Benzodiazepine receptors. , 1985, Clinical neuropharmacology.

[6]  Robert B. Innis,et al.  Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation , 2008, NeuroImage.

[7]  D L Hill,et al.  Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. , 1997, Medical physics.

[8]  Ronald Boellaard,et al.  HRRT Versus HR+ Human Brain PET Studies: An Interscanner Test–Retest Study , 2009, Journal of Nuclear Medicine.

[9]  R. Ownby.  Neuroinflammation and Cognitive Aging , 2010, Current psychiatry reports.

[10]  P S Goldman-Rakic,et al.  Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria. , 1995, Cerebral cortex.

[11]  J. Meyer,et al.  Leuko-araiosis and cerebral perfusion in normal aging. , 1993, Experimental aging research.

[12]  D. Walker,et al.  Evidence that aging and amyloid promote microglial cell senescence. , 2007, Rejuvenation research.

[13]  Ming-Kai Chen,et al.  Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. , 2008, Pharmacology & therapeutics.

[14]  D. Salat,et al.  Prefrontal gray and white matter volumes in healthy aging and Alzheimer disease. , 1999, Archives of neurology.

[15]  Julie Price,et al.  Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease. , 2009, Archives of neurology.

[16]  Roger N Gunn,et al.  An 18-kDa Translocator Protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28 , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  J. C. Torre.  Cardiovascular Risk Factors Promote Brain Hypoperfusion Leading to Cognitive Decline and Dementia , 2012 .

[18]  K. Iwata,et al.  Regional cerebral blood flow changes in aging. , 1986, Acta radiologica. Supplementum.

[19]  G. Kreutzberg,et al.  Microglia: Intrinsic immuneffector cell of the brain , 1995, Brain Research Reviews.

[20]  Claude Comtat,et al.  Assessment of 11C-PE2I Binding to the Neuronal Dopamine Transporter in Humans with the High-Spatial-Resolution PET Scanner HRRT , 2007, Journal of Nuclear Medicine.

[21]  O. Muzik,et al.  Evaluation of age-related changes in translocator protein (TSPO) in human brain using 11C-[R]-PK11195 PET , 2012, Journal of Neuroinflammation.

[22]  H Lechner,et al.  White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. , 1988, Stroke.

[23]  Paul J. Laurienti,et al.  An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets , 2003, NeuroImage.

[24]  D. Head,et al.  Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. , 1997, Cerebral cortex.

[25]  Nikolaus Weiskopf,et al.  A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging , 2009, NeuroImage.

[26]  M. Petit-Taboué,et al.  Brain kinetics and specific binding of [11C]PK 11195 to omega 3 sites in baboons: positron emission tomography study. , 1991, European journal of pharmacology.

[27]  Rodney W. Johnson,et al.  Age and neuroinflammation: a lifetime of psychoneuroimmune consequences. , 2006, Neurologic clinics.

[28]  Roger N Gunn,et al.  In-vivo measurement of activated microglia in dementia , 2001, The Lancet.

[29]  Alexander Hammers,et al.  In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease , 2006, Neurobiology of Disease.

[30]  J. C. de la Torre.  Cardiovascular Risk Factors Promote Brain Hypoperfusion Leading to Cognitive Decline and Dementia , 2012, Cardiovascular psychiatry and neurology.

[31]  Masanori Ichise,et al.  In vivo imaging of microglial activation using a peripheral benzodiazepine ligand, 11C-CB148 and animal PET following ethanol injury in rat striatum: A comparison with 11C-PK11195 , 2007 .

[32]  N. Berman,et al.  Microglial Expression of MHC Class II Increases in Normal Aging of Nonhuman Primates , 1998, Neurobiology of Aging.

[33]  Z Walker,et al.  Microglial activation and amyloid deposition in mild cognitive impairment , 2009, Neurology.

[34]  E. Yoshikawa,et al.  Microglial activation and dopamine terminal loss in early Parkinson's disease , 2005, Annals of neurology.

[35]  R B Banati,et al.  Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK11195 , 2000, Neurology.

[36]  C. Jack,et al.  Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.

[37]  C. Fennema-Notestine,et al.  Effects of age on tissues and regions of the cerebrum and cerebellum , 2001, Neurobiology of Aging.

[38]  D. Borchelt,et al.  Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function , 2012, Neurobiology of Aging.

[39]  A. Thiel,et al.  Imaging of Microglia Activation in Stroke , 2011, Stroke.

[40]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[41]  B. McEwen,et al.  Microglia derived from aging mice exhibit an altered inflammatory profile , 2007, Glia.

[42]  Raphaël Boisgard,et al.  Reduced PBR/TSPO Expression After Minocycline Treatment in a Rat Model of Focal Cerebral Ischemia: A PET Study Using [18F]DPA-714 , 2011, Molecular Imaging and Biology.

[43]  N C Andreasen,et al.  Age-related changes in regional cerebral blood flow among young to mid-life adults. , 1999, Neuroreport.

[44]  Frederik Barkhof,et al.  Microglial activation in healthy aging , 2012, Neurobiology of Aging.

[45]  R. Mrak,et al.  Enlarged and phagocytic, but not primed, interleukin-1α-immunoreactive microglia increase with age in normal human brain , 1998, Acta Neuropathologica.

[46]  P. Goldman-Rakic,et al.  Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the Talairach Coordinate System. , 1995, Cerebral cortex.

[47]  Robert B. Innis,et al.  Mixed-Affinity Binding in Humans with 18-kDa Translocator Protein Ligands , 2011, The Journal of Nuclear Medicine.

[48]  Y. Kitamura,et al.  Senescence-accelerated mouse. Neurochemical studies on aging. , 1996, Annals of the New York Academy of Sciences.

[49]  B. Gelman,et al.  Microglial Cell Activation in Aging and Alzheimer Disease: Partial Linkage with Neurofibrillary Tangle Burden in the Hippocampus , 1997, Journal of neuropathology and experimental neurology.

[50]  William E. Klunk,et al.  PK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET , 2009, Neurobiology of Aging.

[51]  L. Hansson,et al.  Cytokines and memory across the mature life span of women. , 2011, Scandinavian journal of psychology.

[52]  J Versijpt,et al.  PET visualization of microglia in multiple sclerosis patients using [11C]PK11195 , 2003, European journal of neurology.

[53]  H. Braak,et al.  Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease , 2009, Acta Neuropathologica.

[54]  Martin Rossor,et al.  Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study , 2008, Neurobiology of Disease.

[55]  Y. Huang,et al.  Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1β and anti-inflammatory IL-10 cytokines , 2009, Brain, Behavior, and Immunity.

[56]  N L Foster,et al.  PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[57]  M. Block,et al.  Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism , 2005, Progress in Neurobiology.

[58]  Alan A. Wilson,et al.  Voxel-Based Imaging of Translocator Protein 18Kda (TSPO) in High-Resolution PET , 2013, Journal of Cerebral Blood Flow and Metabolism.

[59]  Jerry L Prince,et al.  Measurement of Radiotracer Concentration in Brain Gray Matter Using Positron Emission Tomography: MRI-Based Correction for Partial Volume Effects , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[60]  A. Peters,et al.  Effects of aging on the neuroglial cells and pericytes within area 17 of the rhesus monkey cerebral cortex , 1991, The Anatomical record.

[61]  Alan C. Evans,et al.  A voxel-based morphometric study to determine individual differences in gray matter density associated with age and cognitive change over time. , 2004, Cerebral cortex.

[62]  Makoto Sawada,et al.  Imaging of Peripheral Benzodiazepine Receptor Expression as Biomarkers of Detrimental versus Beneficial Glial Responses in Mouse Models of Alzheimer's and Other CNS Pathologies , 2008, The Journal of Neuroscience.

[63]  Hervé Boutin,et al.  Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[64]  Federico E. Turkheimer,et al.  Identifying improved TSPO PET imaging probes through biomathematics: The impact of multiple TSPO binding sites in vivo , 2012, NeuroImage.

[65]  D. Sparks,et al.  Dystrophic microglia in the aging human brain , 2004, Glia.

[66]  Elizabeth L Sampson,et al.  In vivo detection of microglial activation in frontotemporal dementia , 2004, Annals of neurology.

[67]  C. Martini,et al.  Age-related changes in peripheral benzodiazepine receptors of human platelets. , 1994, Journal of psychiatry & neuroscience : JPN.

[68]  Masanori Ichise,et al.  Correlation between FEPPA uptake and microglia activation in 6-OHDA injured rat brain , 2010, NeuroImage.

[69]  Y. Kitamura,et al.  Senescence‐Accelerated Mouse , 1996 .

[70]  Alan A. Wilson,et al.  Translocator Protein (18 kDa) Polymorphism (rs6971) Explains in-vivo Brain Binding Affinity of the PET Radioligand [18F]-FEPPA , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[71]  J. Nurnberger,et al.  A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. , 1991, Nucleic acids research.

[72]  Jens C. Pruessner,et al.  Regional Frontal Cortical Volumes Decrease Differentially in Aging: An MRI Study to Compare Volumetric Approaches and Voxel-Based Morphometry , 2002, NeuroImage.

[73]  W. Wong,et al.  Age‐related alterations in the dynamic behavior of microglia , 2011, Aging cell.

[74]  M. Bobinski,et al.  Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease , 1997, Neurobiology of Aging.

[75]  W. Streit,et al.  The effects of aging, injury and disease on microglial function: a case for cellular senescence. , 2007, Neuron glia biology.

[76]  Christer Halldin,et al.  Age and disease related changes in the translocator protein (TSPO) system in the human brain: Positron emission tomography measurements with [11C]vinpocetine , 2011, NeuroImage.

[77]  Badreddine Bencherif,et al.  Application of MRI-based partial-volume correction to the analysis of PET images of mu-opioid receptors using statistical parametric mapping. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[78]  Kimberly J. Jenko,et al.  A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[79]  Roger N Gunn,et al.  Two Binding Sites for [3H]PBR28 in Human Brain: Implications for TSPO PET Imaging of Neuroinflammation , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[80]  V. Papadopoulos,et al.  Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders , 2006, Neuroscience.

[81]  R B Banati,et al.  The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.

[82]  S. Yamaguchi,et al.  Effects of aging on regional cerebral blood flow assessed by using technetium Tc 99m hexamethylpropyleneamine oxime single-photon emission tomography with 3D stereotactic surface projection analysis. , 2005, AJNR. American journal of neuroradiology.

[83]  Sylvain Houle,et al.  Quantitation of Translocator Protein Binding in Human Brain with the Novel Radioligand [18F]-FEPPA and Positron Emission Tomography , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[84]  D. Salat,et al.  Selective preservation and degeneration within the prefrontal cortex in aging and Alzheimer disease. , 2001, Archives of neurology.

[85]  R B D'Agostino,et al.  Probability of stroke: a risk profile from the Framingham Study. , 1991, Stroke.

[86]  Sylvain Houle,et al.  Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors. , 2008, Nuclear medicine and biology.

[87]  Masahiro Fujita,et al.  Comparison of [11C]-(R)-PK 11195 and [11C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker , 2010, NeuroImage.

[88]  R Tomczak,et al.  In vivo imaging of activated microglia using [11 C]PK11195 and positron emission tomography in patients after ischemic stroke , 2000, Neuroreport.